{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:31:15Z","timestamp":1793356275819,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cellsig.2026.112925","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:17:19Z","timestamp":1792077439000},"page":"112925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A multi-omics integration identifies ENY2 hypomethylation as a driver of immunosuppression and progression in breast cancer"],"prefix":"10.1016","volume":"150","author":[{"given":"Hong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44178-022-00007-8","article-title":"CACA guidelines for holistic integrative management of breast cancer","volume":"1","author":"Wu","year":"2022","journal-title":"Holist. Integr. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0010","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","article-title":"The great immune escape: understanding the divergent immune response in breast cancer subtypes","volume":"13","author":"Onkar","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cellsig.2026.112925_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1513421","article-title":"Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review","volume":"15","author":"Serrano Garc\u00eda","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2026.112925_bb0030","article-title":"Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery","volume":"16","author":"Kang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1186\/s12967-025-06495-2","article-title":"DNA methylation in breast cancer: early detection and biomarker discovery through current and emerging approaches","volume":"23","author":"Hum","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0040","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1038\/s41467-020-17537-2","article-title":"Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers","volume":"11","author":"Glodzik","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41419-025-07461-y","article-title":"Hypoxia-induced ATF3 escalates breast cancer invasion by increasing collagen deposition via P4HA1","volume":"16","author":"Dhamdhere","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112925_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/or.2023.8496","article-title":"Modulating epigenetic modifications for cancer therapy (review)","volume":"49","author":"Castro-Mu\u00f1oz","year":"2026","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2026.112925_bb0055","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2026","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112925_bb0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/CJI.0000000000000384","article-title":"Molecular and immune correlates of PDCD1 (PD-1), PD-L1 (CD274), and PD-L2 (PDCD1LG2) DNA methylation in triple negative breast cancer","volume":"44","author":"Ralser","year":"2021","journal-title":"J. Immunother."},{"key":"10.1016\/j.cellsig.2026.112925_bb0065","article-title":"DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities","volume":"15","author":"Cai","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112925_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113766","article-title":"Dysregulation of DNA methylation in colorectal cancer: biomarker, immune regulation, and therapeutic potential","volume":"145","author":"Wang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112925_bb0075","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41590-024-01932-8","article-title":"Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation","volume":"25","author":"Zhang","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2026.112925_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.597513","article-title":"Mining the selective remodeling of DNA methylation in promoter regions to identify robust gene-level associations with phenotype","volume":"8","author":"Quan","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cellsig.2026.112925_bb0085","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","article-title":"Mime: a flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection","volume":"23","author":"Liu","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112925_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112925_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cellsig.2026.112925_bb0100","article-title":"ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2(3)","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0105","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112925_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107205","article-title":"Epigenetic modulations in triple-negative breast cancer: therapeutic implications for tumor microenvironment","volume":"204","author":"Zhou","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112925_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119360","article-title":"The mechanism of DNA methylation and miRNA in breast cancer","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/0115680096278978240204162353","article-title":"DNA methylation-based diagnosis and treatment of breast cancer","volume":"25","author":"Peng","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s10142-023-01000-8","article-title":"An integrative analysis of enhancer of yellow 2 homolog (ENY2) as a molecular biomarker in pan-cancer","volume":"23","author":"Chen","year":"2026","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.cellsig.2026.112925_bb0130","article-title":"Integrated multi-omics analysis identifies ENY2 as a predictor of recurrence and a regulator of telomere maintenance in hepatocellula r carcinoma","volume":"12","author":"Li","year":"2026","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112925_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101013","article-title":"Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer","volume":"14","author":"De Marco","year":"2026","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0140","article-title":"Nobiletin enhances doxorubicin sensitivity in osteosarcoma through ER stress-induced apoptosis mediated by the PI3K\/AKT pathway","volume":"16","author":"Liu","year":"2026","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112925_bb0145","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1038\/s41418-021-00759-2","article-title":"Histone H2Bub1 deubiquitylation is essential for mouse development, but does not regulate global RNA polymerase II transcription","volume":"28","author":"Wang","year":"2026","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae1120","article-title":"ATAC and SAGA histone acetyltransferase modules facilitate transcription factor binding to nucleosomes independent of their acetylation activity","volume":"53","author":"Chesnutt","year":"2026","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112925_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152368","article-title":"Mechanistic role of FTO in cancer pathogenesis, immune evasion, chemotherapy resistance, and immunotherapy response","volume":"52","author":"Badraldin","year":"2025","journal-title":"Semin. Oncol."},{"issue":"16","key":"10.1016\/j.cellsig.2026.112925_bb0160","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.2019004108","article-title":"CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy","volume":"137","author":"Soares","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2026.112925_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111436","article-title":"PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines","volume":"138","author":"Lotfinejad","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellsig.2026.112925_bb0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcancer.2019.12.003","article-title":"PD-L1 status in breast cancer: current view and perspectives","volume":"72","author":"Vranic","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cellsig.2026.112925_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584626","article-title":"Regulation of PD-L1 expression by NF-\u03baB in cancer","volume":"11","author":"Antonangeli","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112925_bb0180","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41419-025-07609-w","article-title":"Inflammation and cancer cell survival: TRAF2 as a key player","volume":"16","author":"Albini","year":"2025","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112925_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152365","article-title":"Breast cancer exosomes: managing macrophage polarization and immune regulation in the tumor microenvironment","volume":"52","author":"Mohammad","year":"2025","journal-title":"Semin. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112925_bb0190","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-23-2390","article-title":"Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion","volume":"84","author":"Yan","year":"2024","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112925_bb0195","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s11033-022-07116-7","article-title":"Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-\u03baB pathway","volume":"49","author":"Zhang","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112925_bb0200","article-title":"Whole-genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer","volume":"3","author":"Hai","year":"2022","journal-title":"MedComm (2020)"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600584X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682600584X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:31:31Z","timestamp":1793352691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682600584X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":40,"alternative-id":["S089865682600584X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112925","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-omics integration identifies ENY2 hypomethylation as a driver of immunosuppression and progression in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112925"}}